Literature DB >> 25071336

Atypical causes of cholestasis.

Ken D Nguyen1, Vinay Sundaram1, Walid S Ayoub1.   

Abstract

Cholestatic liver disease consists of a variety of disorders. Primary sclerosing cholangitis and primary biliary cirrhosis are the most commonly recognized cholestatic liver disease in the adult population, while biliary atresia and Alagille syndrome are commonly recognized in the pediatric population. In infants, the causes are usually congenital or inherited. Even though jaundice is a hallmark of cholestasis, it is not always seen in adult patients with chronic liver disease. Patients can have "silent" progressive cholestatic liver disease for years prior to development of symptoms such as jaundice and pruritus. In this review, we will discuss some of the atypical causes of cholestatic liver disease such as benign recurrent intrahepatic cholestasis, progressive familial intrahepatic cholestasis, Alagille Syndrome, biliary atresia, total parenteral nutrition induced cholestasis and cholestasis secondary to drug induced liver injury.

Entities:  

Keywords:  Alagille syndrome; Benign recurrent intrahepatic cholestasis; Biliary atresia; Cholestasis; Drug induced liver injury; Progressive familial intrahepatic cholestasis; Total parenteral nutrition

Mesh:

Year:  2014        PMID: 25071336      PMCID: PMC4110573          DOI: 10.3748/wjg.v20.i28.9418

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  90 in total

1.  Epidemiology of biliary atresia: a population-based study.

Authors:  P W Yoon; J S Bresee; R S Olney; L M James; M J Khoury
Journal:  Pediatrics       Date:  1997-03       Impact factor: 7.124

2.  Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.

Authors:  M Isabel Lucena; Mariam Molokhia; Yufeng Shen; Thomas J Urban; Guruprasad P Aithal; Raúl J Andrade; Christopher P Day; Francisco Ruiz-Cabello; Peter T Donaldson; Camilla Stephens; Munir Pirmohamed; Manuel Romero-Gomez; Jose Maria Navarro; Robert J Fontana; Michael Miller; Max Groome; Emmanuelle Bondon-Guitton; Anita Conforti; Bruno H C Stricker; Alfonso Carvajal; Luisa Ibanez; Qun-Ying Yue; Michel Eichelbaum; Aris Floratos; Itsik Pe'er; Mark J Daly; David B Goldstein; John F Dillon; Matthew R Nelson; Paul B Watkins; Ann K Daly
Journal:  Gastroenterology       Date:  2011-04-12       Impact factor: 22.682

3.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

4.  Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.

Authors:  Tomás Binder; Peter Salaj; Tomás Zima; Libor Vítek
Journal:  J Perinat Med       Date:  2006       Impact factor: 1.901

5.  A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis.

Authors:  Nadia Roncaglia; Anna Locatelli; Alessandra Arreghini; Francesca Assi; Irene Cameroni; John C Pezzullo; Alessandro Ghidini
Journal:  BJOG       Date:  2004-01       Impact factor: 6.531

Review 6.  Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.

Authors:  Dora Brites
Journal:  Ann Hepatol       Date:  2002 Jan-Mar       Impact factor: 2.400

Review 7.  Benign recurrent intrahepatic cholestasis.

Authors:  Velimir A Luketic; Mitchell L Shiffman
Journal:  Clin Liver Dis       Date:  2004-02       Impact factor: 6.126

8.  Cystic biliary atresia: an etiologic and prognostic subgroup.

Authors:  Enrica Caponcelli; Alex S Knisely; Mark Davenport
Journal:  J Pediatr Surg       Date:  2008-09       Impact factor: 2.545

9.  Prevalence of intrahepatic cholestasis of pregnancy in Chile.

Authors:  H Reyes; M C Gonzalez; J Ribalta; H Aburto; C Matus; G Schramm; R Katz; E Medina
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

Review 10.  Progressive familial intrahepatic cholestasis.

Authors:  Anne Davit-Spraul; Emmanuel Gonzales; Christiane Baussan; Emmanuel Jacquemin
Journal:  Orphanet J Rare Dis       Date:  2009-01-08       Impact factor: 4.123

View more
  25 in total

Review 1.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

Review 2.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy.

Authors:  Spencer P Larson; Oormila Kovilam; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2015-10-15       Impact factor: 4.473

Review 4.  Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.

Authors:  Ashley Vander Does; Cynthia Levy; Gil Yosipovitch
Journal:  Am J Clin Dermatol       Date:  2022-07-28       Impact factor: 6.233

5.  The Pitfalls of Febrile Jaundice. A Case Report.

Authors:  Maria Obreja; Andra Teodor; Daniela Leca; Alexandr Ceasovschih; Egidia Miftode
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-05-09

6.  In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.

Authors:  Mathieu Vinken
Journal:  Arch Toxicol       Date:  2018-03-24       Impact factor: 5.153

7.  Neonatal cholestasis mimicking biliary atresia: Could it be urinary tract infection?

Authors:  Noella Maria Delia Pereira; Ira Shah
Journal:  SAGE Open Med Case Rep       Date:  2017-02-27

8.  Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury.

Authors:  Lindsey Devisscher; Mathieu Vinken; Eva Gijbels; Vânia Vilas-Boas; Pieter Annaert; Tamara Vanhaecke
Journal:  Arch Toxicol       Date:  2020-03-10       Impact factor: 5.153

9.  CD62P (P-selectin) expression as a platelet activation marker in patients with liver cirrhosis with and without cholestasis.

Authors:  Sara Hegazy; Maha Elsabaawy; Mohamed Eltabakh; Reham Hammad; Hanan Bedair
Journal:  Clin Exp Hepatol       Date:  2021-06-30

10.  Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.

Authors:  Kerstin Abshagen; Matthias König; Andreas Hoppe; Isabell Müller; Matthias Ebert; Honglei Weng; Herrmann-Georg Holzhütter; Ulrich M Zanger; Johannes Bode; Brigitte Vollmar; Maria Thomas; Steven Dooley
Journal:  BMC Syst Biol       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.